| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 2.93e-07 | 18 | 166 | 5 | GO:0008569 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 5.66e-07 | 37 | 166 | 6 | GO:0045505 | |
| GeneOntologyMolecularFunction | retinoid binding | 2.77e-06 | 48 | 166 | 6 | GO:0005501 | |
| GeneOntologyMolecularFunction | isoprenoid binding | 3.14e-06 | 49 | 166 | 6 | GO:0019840 | |
| GeneOntologyMolecularFunction | retinoic acid binding | 3.15e-06 | 28 | 166 | 5 | GO:0001972 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 3.15e-06 | 28 | 166 | 5 | GO:0051959 | |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 9.92e-06 | 35 | 166 | 5 | GO:0015020 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 2.55e-05 | 70 | 166 | 6 | GO:0003777 | |
| GeneOntologyMolecularFunction | hexosyltransferase activity | 3.94e-04 | 211 | 166 | 8 | GO:0016758 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 4.61e-04 | 118 | 166 | 6 | GO:0003774 | |
| GeneOntologyMolecularFunction | carboxylic acid binding | 8.93e-04 | 239 | 166 | 8 | GO:0031406 | |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 5.83e-07 | 21 | 166 | 5 | GO:0052695 | |
| GeneOntologyBiologicalProcess | cilium movement | KIF27 TTC21A DRC1 DNAH7 CATSPER1 DNAH12 DNAH17 ROPN1B ROPN1 DYNC1H1 CFAP157 DNAH11 | 1.42e-06 | 261 | 166 | 12 | GO:0003341 |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 1.82e-06 | 26 | 166 | 5 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 1.82e-06 | 26 | 166 | 5 | GO:0006063 | |
| GeneOntologyBiologicalProcess | cilium movement involved in cell motility | TTC21A DRC1 DNAH7 CATSPER1 DNAH12 DNAH17 ROPN1B ROPN1 CFAP157 DNAH11 | 8.08e-06 | 210 | 166 | 10 | GO:0060294 |
| GeneOntologyBiologicalProcess | cilium-dependent cell motility | TTC21A DRC1 DNAH7 CATSPER1 DNAH12 DNAH17 ROPN1B ROPN1 CFAP157 DNAH11 | 9.93e-06 | 215 | 166 | 10 | GO:0060285 |
| GeneOntologyBiologicalProcess | cilium or flagellum-dependent cell motility | TTC21A DRC1 DNAH7 CATSPER1 DNAH12 DNAH17 ROPN1B ROPN1 CFAP157 DNAH11 | 9.93e-06 | 215 | 166 | 10 | GO:0001539 |
| GeneOntologyBiologicalProcess | glial cell fate specification | 4.15e-05 | 9 | 166 | 3 | GO:0021780 | |
| GeneOntologyBiologicalProcess | xenobiotic glucuronidation | 1.07e-04 | 12 | 166 | 3 | GO:0052697 | |
| GeneOntologyCellularComponent | dynein complex | 4.17e-06 | 54 | 165 | 6 | GO:0030286 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | AKAP6 APH1B PIGB ABCA1 RHBDF2 PIGK UGT1A5 RDH14 RTN3 RTN1 STT3B MAP3K5 UGT1A4 UGT1A3 VKORC1 SYNE3 TMEM203 STX5 SGMS1 CLCN4 IZUMO1 TM7SF2 UGT2B15 UGT2B17 ABCC12 ATP2A1 | 1.57e-05 | 1327 | 165 | 26 | GO:0042175 |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | AKAP6 APH1B PIGB ABCA1 RHBDF2 PIGK UGT1A5 RDH14 RTN3 RTN1 STT3B MAP3K5 UGT1A4 UGT1A3 VKORC1 TMEM203 STX5 SGMS1 CLCN4 IZUMO1 TM7SF2 UGT2B15 UGT2B17 ABCC12 ATP2A1 | 2.91e-05 | 1293 | 165 | 25 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | AKAP6 APH1B PIGB ABCA1 RHBDF2 PIGK UGT1A5 RDH14 RTN3 RTN1 STT3B MAP3K5 UGT1A4 UGT1A3 VKORC1 TMEM203 STX5 SGMS1 CLCN4 IZUMO1 TM7SF2 UGT2B15 UGT2B17 ABCC12 ATP2A1 | 3.14e-05 | 1299 | 165 | 25 | GO:0098827 |
| GeneOntologyCellularComponent | axonemal dynein complex | 4.16e-05 | 25 | 165 | 4 | GO:0005858 | |
| GeneOntologyCellularComponent | microtubule associated complex | 4.29e-05 | 161 | 165 | 8 | GO:0005875 | |
| GeneOntologyCellularComponent | sperm cytoplasmic droplet | 6.10e-04 | 5 | 165 | 2 | GO:0097598 | |
| GeneOntologyCellularComponent | 9+2 motile cilium | 6.22e-04 | 238 | 165 | 8 | GO:0097729 | |
| Domain | UDPGT | 8.39e-07 | 21 | 162 | 5 | PF00201 | |
| Domain | UDPGT | 8.39e-07 | 21 | 162 | 5 | PS00375 | |
| Domain | UDP_glucos_trans | 8.39e-07 | 21 | 162 | 5 | IPR002213 | |
| Domain | Dynein_heavy_chain_D4_dom | 5.10e-06 | 14 | 162 | 4 | IPR024317 | |
| Domain | Dynein_heavy_dom-2 | 5.10e-06 | 14 | 162 | 4 | IPR013602 | |
| Domain | DHC_N2 | 5.10e-06 | 14 | 162 | 4 | PF08393 | |
| Domain | AAA_8 | 5.10e-06 | 14 | 162 | 4 | PF12780 | |
| Domain | DHC_fam | 6.91e-06 | 15 | 162 | 4 | IPR026983 | |
| Domain | Dynein_heavy | 6.91e-06 | 15 | 162 | 4 | PF03028 | |
| Domain | Dynein_heavy_dom | 6.91e-06 | 15 | 162 | 4 | IPR004273 | |
| Domain | SPEC | 7.69e-06 | 32 | 162 | 5 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 7.69e-06 | 32 | 162 | 5 | IPR018159 | |
| Domain | PH_dom-spectrin-type | 5.18e-05 | 9 | 162 | 3 | IPR001605 | |
| Domain | DVL-1 | 7.48e-05 | 2 | 162 | 2 | IPR008340 | |
| Domain | ATM/Tel1 | 7.48e-05 | 2 | 162 | 2 | IPR015519 | |
| Domain | Spectrin_repeat | 1.09e-04 | 29 | 162 | 4 | IPR002017 | |
| Domain | Dynein_HC_stalk | 2.17e-04 | 14 | 162 | 3 | IPR024743 | |
| Domain | ATPase_dyneun-rel_AAA | 2.17e-04 | 14 | 162 | 3 | IPR011704 | |
| Domain | MT | 2.17e-04 | 14 | 162 | 3 | PF12777 | |
| Domain | AAA_5 | 2.17e-04 | 14 | 162 | 3 | PF07728 | |
| Domain | CH | 4.31e-04 | 73 | 162 | 5 | PS50021 | |
| Domain | CTF_NFI | 4.44e-04 | 4 | 162 | 2 | PF00859 | |
| Domain | CTF_NFI_1 | 4.44e-04 | 4 | 162 | 2 | PS00349 | |
| Domain | CTF_NFI_2 | 4.44e-04 | 4 | 162 | 2 | PS51080 | |
| Domain | Dishevelled | 4.44e-04 | 4 | 162 | 2 | PF02377 | |
| Domain | CTF/NFI_DNA-bd-dom | 4.44e-04 | 4 | 162 | 2 | IPR020604 | |
| Domain | NfI_DNAbd_pre-N | 4.44e-04 | 4 | 162 | 2 | PF10524 | |
| Domain | CTF/NFI | 4.44e-04 | 4 | 162 | 2 | IPR000647 | |
| Domain | Dishevelled_fam | 4.44e-04 | 4 | 162 | 2 | IPR008339 | |
| Domain | CTF/NFI_DNA-bd_N | 4.44e-04 | 4 | 162 | 2 | IPR019548 | |
| Domain | CTF/NFI_DNA-bd_CS | 4.44e-04 | 4 | 162 | 2 | IPR019739 | |
| Domain | Dishevelled_protein_dom | 4.44e-04 | 4 | 162 | 2 | IPR003351 | |
| Domain | CH-domain | 4.88e-04 | 75 | 162 | 5 | IPR001715 | |
| Domain | FATC | 7.35e-04 | 5 | 162 | 2 | PF02260 | |
| Domain | RETICULON | 7.35e-04 | 5 | 162 | 2 | PS50845 | |
| Domain | Spectrin | 9.99e-04 | 23 | 162 | 3 | PF00435 | |
| Domain | ACTININ_2 | 9.99e-04 | 23 | 162 | 3 | PS00020 | |
| Domain | ACTININ_1 | 9.99e-04 | 23 | 162 | 3 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 9.99e-04 | 23 | 162 | 3 | IPR001589 | |
| Domain | AA_TRANSFER_CLASS_1 | 1.10e-03 | 6 | 162 | 2 | PS00105 | |
| Domain | - | 1.10e-03 | 6 | 162 | 2 | 3.90.1290.10 | |
| Domain | FAT | 1.10e-03 | 6 | 162 | 2 | PS51189 | |
| Domain | FATC | 1.10e-03 | 6 | 162 | 2 | PS51190 | |
| Domain | FATC_dom | 1.10e-03 | 6 | 162 | 2 | IPR003152 | |
| Domain | PIK_FAT | 1.10e-03 | 6 | 162 | 2 | IPR014009 | |
| Domain | FATC | 1.10e-03 | 6 | 162 | 2 | SM01343 | |
| Domain | Munc13_1 | 1.53e-03 | 7 | 162 | 2 | IPR014770 | |
| Domain | MHD1 | 1.53e-03 | 7 | 162 | 2 | PS51258 | |
| Domain | Plectin | 1.53e-03 | 7 | 162 | 2 | PF00681 | |
| Domain | DUF1041 | 1.53e-03 | 7 | 162 | 2 | PF06292 | |
| Domain | Plectin_repeat | 1.53e-03 | 7 | 162 | 2 | IPR001101 | |
| Domain | CAPS_dom | 1.53e-03 | 7 | 162 | 2 | IPR010439 | |
| Domain | DIX | 1.53e-03 | 7 | 162 | 2 | PF00778 | |
| Domain | Reticulon | 1.53e-03 | 7 | 162 | 2 | PF02453 | |
| Domain | DIX | 1.53e-03 | 7 | 162 | 2 | IPR001158 | |
| Domain | DIX | 1.53e-03 | 7 | 162 | 2 | PS50841 | |
| Domain | DAX | 1.53e-03 | 7 | 162 | 2 | SM00021 | |
| Domain | PLEC | 1.53e-03 | 7 | 162 | 2 | SM00250 | |
| Domain | AAA | 1.62e-03 | 144 | 162 | 6 | SM00382 | |
| Domain | AAA+_ATPase | 1.62e-03 | 144 | 162 | 6 | IPR003593 | |
| Domain | DHC_N1 | 2.02e-03 | 8 | 162 | 2 | PF08385 | |
| Domain | Reticulon | 2.02e-03 | 8 | 162 | 2 | IPR003388 | |
| Domain | Dynein_heavy_dom-1 | 2.02e-03 | 8 | 162 | 2 | IPR013594 | |
| Domain | CH | 2.45e-03 | 65 | 162 | 4 | SM00033 | |
| Domain | CH | 3.21e-03 | 70 | 162 | 4 | PF00307 | |
| Domain | ALDOKETO_REDUCTASE_1 | 3.21e-03 | 10 | 162 | 2 | PS00798 | |
| Domain | ALDOKETO_REDUCTASE_2 | 3.21e-03 | 10 | 162 | 2 | PS00062 | |
| Domain | ALDOKETO_REDUCTASE_3 | 3.21e-03 | 10 | 162 | 2 | PS00063 | |
| Domain | Aldo/ket_reductase_CS | 3.21e-03 | 10 | 162 | 2 | IPR018170 | |
| Domain | Aldo/keto_reductase | 3.21e-03 | 10 | 162 | 2 | IPR020471 | |
| Domain | - | 3.37e-03 | 71 | 162 | 4 | 1.10.418.10 | |
| Domain | PH | 3.90e-03 | 229 | 162 | 7 | PF00169 | |
| Domain | MAD_homology1_Dwarfin-type | 4.66e-03 | 12 | 162 | 2 | IPR003619 | |
| Domain | DWA | 4.66e-03 | 12 | 162 | 2 | SM00523 | |
| Domain | MH1 | 4.66e-03 | 12 | 162 | 2 | PF03165 | |
| Domain | TUDOR | 6.35e-03 | 14 | 162 | 2 | PF00567 | |
| Domain | PI3/4_kinase_CS | 7.29e-03 | 15 | 162 | 2 | IPR018936 | |
| Domain | cAMP_dep_PK_reg_su_I/II_a/b | 7.29e-03 | 15 | 162 | 2 | IPR003117 | |
| Domain | - | 8.28e-03 | 16 | 162 | 2 | 1.10.1070.11 | |
| Domain | Nicotinic_acetylcholine_rcpt | 8.28e-03 | 16 | 162 | 2 | IPR002394 | |
| Domain | PI3Kc | 8.28e-03 | 16 | 162 | 2 | SM00146 | |
| Domain | - | 8.28e-03 | 16 | 162 | 2 | 3.20.20.100 | |
| Pathway | REACTOME_PREDNISONE_ADME | 1.38e-06 | 23 | 123 | 5 | MM16639 | |
| Pathway | REACTOME_GLUCURONIDATION | 1.73e-06 | 24 | 123 | 5 | MM14599 | |
| Pathway | REACTOME_GLUCURONIDATION | 2.15e-06 | 25 | 123 | 5 | M17787 | |
| Pathway | WP_GLUCURONIDATION | 2.15e-06 | 25 | 123 | 5 | MM15820 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 2.15e-06 | 25 | 123 | 5 | M605 | |
| Pathway | WP_GLUCURONIDATION | 2.65e-06 | 26 | 123 | 5 | M39404 | |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 3.90e-06 | 28 | 123 | 5 | M19580 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 7.98e-06 | 55 | 123 | 6 | M14933 | |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | 2.72e-05 | 41 | 123 | 5 | M7399 | |
| Pathway | REACTOME_ASPIRIN_ADME | 3.85e-05 | 44 | 123 | 5 | M45014 | |
| Pathway | REACTOME_ASPIRIN_ADME | 4.31e-05 | 45 | 123 | 5 | MM15694 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 7.94e-05 | 51 | 123 | 5 | M17726 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 8.29e-05 | 27 | 123 | 4 | M47755 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 8.73e-05 | 52 | 123 | 5 | M14171 | |
| Pathway | KEGG_RETINOL_METABOLISM | 2.36e-04 | 64 | 123 | 5 | M9488 | |
| Pathway | REACTOME_ATORVASTATIN_ADME | 2.73e-04 | 15 | 123 | 3 | MM15697 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 3.59e-04 | 70 | 123 | 5 | M16794 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 4.09e-04 | 72 | 123 | 5 | M9257 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 5.24e-04 | 43 | 123 | 4 | M47669 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 6.24e-04 | 45 | 123 | 4 | M47670 | |
| Pathway | REACTOME_HEME_DEGRADATION | 6.63e-04 | 20 | 123 | 3 | MM14721 | |
| Pubmed | 4.79e-09 | 14 | 168 | 5 | 9373155 | ||
| Pubmed | 3.62e-08 | 8 | 168 | 4 | 22579593 | ||
| Pubmed | Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans. | 2.52e-07 | 12 | 168 | 4 | 20308471 | |
| Pubmed | 4.41e-07 | 4 | 168 | 3 | 26176234 | ||
| Pubmed | Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation. | 5.06e-07 | 14 | 168 | 4 | 14672974 | |
| Pubmed | 1.10e-06 | 5 | 168 | 3 | 16627753 | ||
| Pubmed | USP53 plays an antitumor role in hepatocellular carcinoma through deubiquitination of cytochrome c. | 5.17e-06 | 90 | 168 | 6 | 35654790 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | EPPK1 KIF27 SMCHD1 VPS33A DDX42 CCNB1 ANLN PARVA OXSR1 ATM NUP93 PLEC DYNC1H1 | 5.64e-06 | 582 | 168 | 13 | 20467437 |
| Pubmed | The transcription factor Sox5 modulates Sox10 function during melanocyte development. | 6.09e-06 | 8 | 168 | 3 | 18703590 | |
| Pubmed | 6.09e-06 | 8 | 168 | 3 | 18719240 | ||
| Pubmed | 6.09e-06 | 8 | 168 | 3 | 20142249 | ||
| Pubmed | Involvement of human UGT2B7 and 2B15 in rofecoxib metabolism. | 6.09e-06 | 8 | 168 | 3 | 12695355 | |
| Pubmed | 9.10e-06 | 9 | 168 | 3 | 22511988 | ||
| Pubmed | 9.10e-06 | 9 | 168 | 3 | 1339448 | ||
| Pubmed | 1.30e-05 | 10 | 168 | 3 | 23642732 | ||
| Pubmed | 1.30e-05 | 10 | 168 | 3 | 11465080 | ||
| Pubmed | 1.30e-05 | 10 | 168 | 3 | 10037800 | ||
| Pubmed | 1.30e-05 | 10 | 168 | 3 | 23371916 | ||
| Pubmed | A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia. | 1.30e-05 | 10 | 168 | 3 | 22558097 | |
| Pubmed | 1.78e-05 | 11 | 168 | 3 | 16678811 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 8068691 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 31565865 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 23761073 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 32660355 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 17499243 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 9524265 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 24641623 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 31757807 | ||
| Pubmed | hSMG-1 and ATM sequentially and independently regulate the G1 checkpoint during oxidative stress. | 2.32e-05 | 2 | 168 | 2 | 18332866 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 1909870 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 24121496 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 24267955 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 22170718 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 34070827 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 30511336 | ||
| Pubmed | Localization of UDP glucuronosyltransferase gene(s) on mouse chromosome 5. | 2.32e-05 | 2 | 168 | 2 | 3105095 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 17848572 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 27496708 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 8644734 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 11585348 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 17698910 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 35986423 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 16148004 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 22406075 | ||
| Pubmed | Mutational alterations of TDRD 1, 4 and 9 genes in colorectal cancers. | 2.32e-05 | 2 | 168 | 2 | 32036563 | |
| Pubmed | Recurrent major depression and right hippocampal volume: A bivariate linkage and association study. | 2.32e-05 | 2 | 168 | 2 | 26485182 | |
| Pubmed | Mouse UDP glucuronosyltransferase. cDNA and complete amino acid sequence and regulation. | 2.32e-05 | 2 | 168 | 2 | 3117546 | |
| Pubmed | Generation of mice harboring a Sox5 conditional null allele. | 2.32e-05 | 2 | 168 | 2 | 18543318 | |
| Pubmed | RTN1 and RTN3 protein are differentially associated with senile plaques in Alzheimer's brains. | 2.32e-05 | 2 | 168 | 2 | 28733667 | |
| Pubmed | WSB1 overcomes oncogene-induced senescence by targeting ATM for degradation. | 2.32e-05 | 2 | 168 | 2 | 27958289 | |
| Pubmed | TIMELESS upregulates PD-L1 expression and exerts an immunosuppressive role in breast cancer. | 2.32e-05 | 2 | 168 | 2 | 37340461 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 28971736 | ||
| Pubmed | Association between circadian genes, bipolar disorders and chronotypes. | 2.32e-05 | 2 | 168 | 2 | 24716566 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 28228532 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 14570768 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 15666817 | ||
| Pubmed | 2.36e-05 | 12 | 168 | 3 | 19419973 | ||
| Pubmed | 2.36e-05 | 12 | 168 | 3 | 34234180 | ||
| Pubmed | 2.36e-05 | 12 | 168 | 3 | 26525805 | ||
| Pubmed | 2.36e-05 | 12 | 168 | 3 | 18161889 | ||
| Pubmed | Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. | 2.36e-05 | 12 | 168 | 3 | 11434514 | |
| Pubmed | UGT1A1 is a major locus influencing bilirubin levels in African Americans. | 3.06e-05 | 13 | 168 | 3 | 22085899 | |
| Pubmed | Genome-wide analysis of hepatic lipid content in extreme obesity. | 3.06e-05 | 13 | 168 | 3 | 25246029 | |
| Pubmed | 3.88e-05 | 14 | 168 | 3 | 21646302 | ||
| Pubmed | 3.88e-05 | 14 | 168 | 3 | 8921394 | ||
| Pubmed | Human UDP-glucuronosyltransferases: metabolism, expression, and disease. | 3.88e-05 | 14 | 168 | 3 | 10836148 | |
| Pubmed | 3.88e-05 | 14 | 168 | 3 | 9295054 | ||
| Pubmed | Differential isoform expression and alternative splicing in sex determination in mice. | 4.83e-05 | 15 | 168 | 3 | 30871468 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | EPPK1 ITSN1 WTAP TASOR2 OXSR1 ATM PLEC CAMSAP1 FHIP1A DYNC1H1 | 4.99e-05 | 430 | 168 | 10 | 35044719 |
| Pubmed | 5.60e-05 | 43 | 168 | 4 | 21116278 | ||
| Pubmed | Genome-wide association meta-analysis for total serum bilirubin levels. | 5.92e-05 | 16 | 168 | 3 | 19414484 | |
| Pubmed | SMG1 PIGK VPS33A IFI35 DNAH7 FER1L6 VKORC1 DNAH12 NFIA TAF2 DNAH11 FAM149A | 6.90e-05 | 638 | 168 | 12 | 31182584 | |
| Pubmed | SoxD genes are required for adult neural stem cell activation. | 6.94e-05 | 3 | 168 | 2 | 35108528 | |
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 22887640 | ||
| Pubmed | ASK1 facilitates tumor metastasis through phosphorylation of an ADP receptor P2Y12 in platelets. | 6.94e-05 | 3 | 168 | 2 | 28753204 | |
| Pubmed | SMCHD1 promotes ATM-dependent DNA damage signaling and repair of uncapped telomeres. | 6.94e-05 | 3 | 168 | 2 | 32080884 | |
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 19572376 | ||
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 12873973 | ||
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 26045173 | ||
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 26385605 | ||
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 12051676 | ||
| Pubmed | STT3-dependent PD-L1 accumulation on cancer stem cells promotes immune evasion. | 6.94e-05 | 3 | 168 | 2 | 29765039 | |
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 18270262 | ||
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 31128945 | ||
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 23303679 | ||
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 8666668 | ||
| Pubmed | STK39 is an independent risk factor for male hypertension in Han Chinese. | 6.94e-05 | 3 | 168 | 2 | 20889219 | |
| Pubmed | Mammalian TIMELESS is required for ATM-dependent CHK2 activation and G2/M checkpoint control. | 6.94e-05 | 3 | 168 | 2 | 19996108 | |
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 28343969 | ||
| Pubmed | SPAK and OSR1 Sensitivity of Excitatory Amino Acid Transporter EAAT3. | 6.94e-05 | 3 | 168 | 2 | 26112741 | |
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 36056297 | ||
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 21383159 | ||
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 11854008 | ||
| Pubmed | The transcription factors Sox5 and Sox9 regulate Catsper1 gene expression. | 6.94e-05 | 3 | 168 | 2 | 25101494 | |
| Pubmed | Regulation of Human UGT2B15 and UGT2B17 by miR-376c in Prostate Cancer Cell Lines. | 6.94e-05 | 3 | 168 | 2 | 26163549 | |
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 30254023 | ||
| Pubmed | Loss of ASP but not ROPN1 reduces mammalian ciliary motility. | 6.94e-05 | 3 | 168 | 2 | 22021175 | |
| Pubmed | SPAK isoforms and OSR1 regulate sodium-chloride co-transporters in a nephron-specific manner. | 6.94e-05 | 3 | 168 | 2 | 22977235 | |
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 20736324 | ||
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 26150426 | ||
| Interaction | DNAH11 interactions | 1.85e-06 | 12 | 161 | 4 | int:DNAH11 | |
| Interaction | C3orf18 interactions | 4.00e-06 | 115 | 161 | 8 | int:C3orf18 | |
| Interaction | GYPA interactions | 1.12e-05 | 174 | 161 | 9 | int:GYPA | |
| Interaction | UBA6 interactions | 2.81e-05 | 150 | 161 | 8 | int:UBA6 | |
| Cytoband | 2q37 | 2.01e-04 | 31 | 168 | 3 | 2q37 | |
| Cytoband | 9p24 | 3.67e-04 | 8 | 168 | 2 | 9p24 | |
| GeneFamily | UDP glucuronosyltransferases | 1.23e-06 | 32 | 108 | 5 | 363 | |
| GeneFamily | Dyneins, axonemal | 2.70e-06 | 17 | 108 | 4 | 536 | |
| GeneFamily | SRY-boxes | 1.87e-04 | 19 | 108 | 3 | 757 | |
| GeneFamily | EF-hand domain containing|Spectrins | 7.28e-04 | 7 | 108 | 2 | 1113 | |
| GeneFamily | EF-hand domain containing|Plakins | 9.67e-04 | 8 | 108 | 2 | 939 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.48e-03 | 206 | 108 | 6 | 682 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | AKAP6 KIF27 TTC21A DNAH7 DNAH12 DZIP3 CCDC191 CFAP157 DNAH11 | 5.32e-08 | 194 | 167 | 9 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 |
| ToppCell | LPS-antiTNF-Endothelial-Epi-like-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.02e-07 | 150 | 167 | 8 | 9cb3332924bd67c966873343c14445e30d3f384f | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.64e-07 | 177 | 167 | 8 | 9af14a056eb6d88c6f11b09f6d4c0d3448d647d5 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_VISp_Col8a1_Rxfp1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.49e-07 | 131 | 167 | 7 | 81efe8b0ca4377e557a42ddb12aecaf3f46b15bf | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.18e-07 | 197 | 167 | 8 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Ciliated|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 9.17e-07 | 200 | 167 | 8 | 6a2ccc71a0cbe04a542c379b28b5006de53981c3 | |
| ToppCell | Control-MAIT|World / Disease group and Cell class | 2.80e-06 | 163 | 167 | 7 | 0ca4b835936b4f82217cbe57210c1dd90986c1d0 | |
| ToppCell | Ciliated_cells-A-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 2.80e-06 | 163 | 167 | 7 | 43194c6127df1ce3d29242f719645de3c11fd7c0 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.56e-06 | 169 | 167 | 7 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.15e-06 | 173 | 167 | 7 | c3762655caa79ac4879876f470d32578a3c93b01 | |
| ToppCell | droplet-Liver-Npc-18m-Myeloid-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-06 | 173 | 167 | 7 | 9ba55e21d1037ec3150d77895e52f0b051df65da | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Radial_glial-RGCs_early_2|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 4.65e-06 | 176 | 167 | 7 | 8e0ac3ad5e47614b4befabd674a40e3eaae553f3 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.01e-06 | 178 | 167 | 7 | 3b12db04006db6e94fc45649a4b3a63b92f21a61 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.20e-06 | 179 | 167 | 7 | adf8b025032a03dbb58871a92025cd7efbeb22ff | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.20e-06 | 179 | 167 | 7 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.39e-06 | 180 | 167 | 7 | 92fb01b91261b3103454924cde56add337b41844 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.45e-06 | 185 | 167 | 7 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 7.17e-06 | 188 | 167 | 7 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.17e-06 | 188 | 167 | 7 | 58ccb31cdf43167872ef0fc737e6f9c51ee2e060 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-F_(Ciliated)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.95e-06 | 191 | 167 | 7 | dad675251e129254955eac179c84a641a4864586 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-F_(Ciliated)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.95e-06 | 191 | 167 | 7 | 6d2cf41ee946137c039ddcc13593fc3f670afbba | |
| ToppCell | ASK452-Epithelial-Ciliated|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 8.50e-06 | 193 | 167 | 7 | c0d10075862ac878aa05fc49c8b73e470783bf16 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.50e-06 | 193 | 167 | 7 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | ASK440-Epithelial-Ciliated|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 8.80e-06 | 194 | 167 | 7 | c84a7fa94fb06e08aae04db56c8c313b0afde1d7 | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_1|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 8.80e-06 | 194 | 167 | 7 | b4ce60c06568123008b1081d644733cb91c28f51 | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 8.80e-06 | 194 | 167 | 7 | 7a7ddccfe72a4a0dc4d1a5c809988f0069f9f1a3 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.09e-06 | 195 | 167 | 7 | 79dc031258579ea328181dda33710dd897f1064a | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.09e-06 | 195 | 167 | 7 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | control-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.72e-06 | 197 | 167 | 7 | e453d085182364ca347cbcc9dc995c62c3353016 | |
| ToppCell | control-Epithelial-Ciliated|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.72e-06 | 197 | 167 | 7 | d4e963c1f82996371bf3d63578ee9fce8e00c5a8 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.96e-05 | 147 | 167 | 6 | 94998bc40f5c08295cfe3bdcbe43f13b1e564b3d | |
| ToppCell | COVID-19-Epithelial_cells-Airway_mucous|COVID-19 / group, cell type (main and fine annotations) | 2.28e-05 | 151 | 167 | 6 | 8216462e723fec2797387929dde095370947e10a | |
| ToppCell | NS-moderate-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.84e-05 | 157 | 167 | 6 | 410c9d74a2085179cfb39853cb6d330fa98c9c1b | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.05e-05 | 159 | 167 | 6 | fd7db2f7328cfefdc3ada2af91006d5a91d137e1 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.05e-05 | 159 | 167 | 6 | aaf449c768d6fbb0a1bb47746ff3bdb7f9eb8914 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.05e-05 | 159 | 167 | 6 | 8bbdef1e927f3130b578d7d7c5ff38bbe06fab63 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.16e-05 | 160 | 167 | 6 | 7064af50fc10e3ea03badf415306222b74db0f95 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.27e-05 | 161 | 167 | 6 | 4bb7bae54ba3bdf46b525c01f5ad3db8e49819cb | |
| ToppCell | PND01-03-samps|World / Age Group, Lineage, Cell class and subclass | 3.27e-05 | 161 | 167 | 6 | 1973b112d8d67aacc02751797d0148e7b53bfa66 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_KRT17|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.88e-05 | 166 | 167 | 6 | 739dfbe927f409821ff23aca6e47ebe78f57e859 | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.88e-05 | 166 | 167 | 6 | 9adceb746e67e955fd8b3e0984f4eed44b64a270 | |
| ToppCell | Ciliated_cells-B-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 3.88e-05 | 166 | 167 | 6 | 4b1056aad8a99827835242b8ab0c7f2bb84471f1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.02e-05 | 167 | 167 | 6 | 108ae6221c6edc63c0ec42c42471b3a15a594043 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.15e-05 | 168 | 167 | 6 | 9a8709d34865cfa668d8f3335dc34fc86fc32482 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.29e-05 | 169 | 167 | 6 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | COVID-19_Moderate-Treg|World / disease group, cell group and cell class | 4.29e-05 | 169 | 167 | 6 | 27ad11239559b025bef582f89b2a83501d9d3993 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_KRT17|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.43e-05 | 170 | 167 | 6 | 84d49a1f2989d98bd0acf9ec2d59f1042fc0f55b | |
| ToppCell | Control-MAIT|Control / Disease group and Cell class | 4.73e-05 | 172 | 167 | 6 | 552bc62e8e8bb0ac1cd0452f4410a3af087787eb | |
| ToppCell | AT1-AT2_cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 5.21e-05 | 175 | 167 | 6 | bdd85ba280648a0283c1984662a34c7b840f64dd | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.21e-05 | 175 | 167 | 6 | 442f261a3b2c4d2523f7d4089178f8c79cac2f0f | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.21e-05 | 175 | 167 | 6 | 35fb7735dd3355476fe60404833cb60bd066bcf1 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.38e-05 | 176 | 167 | 6 | dee780cfa85234a7cd7bf440b66b84cec959893e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.73e-05 | 178 | 167 | 6 | 51d2188406f04329311b2efd1108fc36617a860e | |
| ToppCell | 15-Airway-Epithelial-Multiciliated_precursor|Airway / Age, Tissue, Lineage and Cell class | 5.73e-05 | 178 | 167 | 6 | d8e0a696bdd6af6422d72af0413f9dbd6bc02afa | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-4|TCGA-Breast / Sample_Type by Project: Shred V9 | 5.73e-05 | 178 | 167 | 6 | 44b5ba4e8788d3973749a1717e427647ac4c8579 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.09e-05 | 180 | 167 | 6 | 1f1af4474f3f0ac3c0d6b1a6c875c354d36d8eec | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.28e-05 | 181 | 167 | 6 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.48e-05 | 182 | 167 | 6 | 5f513bbb7125956eb528e3120de3fd776770a7c3 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 6.68e-05 | 183 | 167 | 6 | 310ad42b2b5d8ddd01d3a12db338f80ac1f5d08e | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.68e-05 | 183 | 167 | 6 | fef51dcf180e6d4e136362c7e140ec5ef372e6d0 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.68e-05 | 183 | 167 | 6 | 2e831a4d99c6f983793df71c0994124c943c6da9 | |
| ToppCell | wk_08-11-Epithelial-PNS-PCP4+_neuron|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 6.88e-05 | 184 | 167 | 6 | eac2a9089913f33a961ba11519b53645790f2056 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.09e-05 | 185 | 167 | 6 | d602a9b35e86e6f2a14a58e40fc4fb97f5fa3b08 | |
| ToppCell | 15-Airway-Epithelial-Multiciliated_cell|Airway / Age, Tissue, Lineage and Cell class | 7.09e-05 | 185 | 167 | 6 | 0998b6bf44287eebbf39249fff23fc3689e44c4e | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.09e-05 | 185 | 167 | 6 | 8207f9eff113eed429e961748c6b17d672a13b33 | |
| ToppCell | facs-Trachea-18m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l54|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.09e-05 | 185 | 167 | 6 | 59acaf025353405948dc34ccccf37ec5c08ea903 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.30e-05 | 186 | 167 | 6 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.30e-05 | 186 | 167 | 6 | 337f768cc43db2db96ba6495b076006b1a5b0331 | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.30e-05 | 186 | 167 | 6 | e378c82ef6d6cb24751515aa499a01372b3e7ccf | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.30e-05 | 186 | 167 | 6 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c | |
| ToppCell | droplet-Spleen-nan-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.52e-05 | 187 | 167 | 6 | c81d11d9fdc22dc39222f62c2888025c2e8c3e65 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.75e-05 | 188 | 167 | 6 | eea652bab161f19148a883e7e3fe2523b36b3cea | |
| ToppCell | multiciliated|World / shred by cell class for bronchial biopsy | 7.75e-05 | 188 | 167 | 6 | 6833c1f0f265ef5448fa65033550ed7efc2f8d7b | |
| ToppCell | COVID-19-kidney-DCT|kidney / Disease (COVID-19 only), tissue and cell type | 7.75e-05 | 188 | 167 | 6 | df1fd0819d301679f3c9ea404e942e39095912eb | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.75e-05 | 188 | 167 | 6 | eec3d353e51358db4c7621265ee0fdd4298e5b0e | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-F_(Ciliated)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 7.75e-05 | 188 | 167 | 6 | 5ba5cbb403518026e9040379fb5d99339ea977d8 | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 7.75e-05 | 188 | 167 | 6 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.98e-05 | 189 | 167 | 6 | 02c6128a9ab5818e0881dcadafdad5f08b9a67cf | |
| ToppCell | COVID-19-lung-Ciliated|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.98e-05 | 189 | 167 | 6 | a2da5debd10f27b1280b40141ef0bfef007cc72c | |
| ToppCell | 343B-Epithelial_cells-Epithelial-F_(Ciliated)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.98e-05 | 189 | 167 | 6 | 57ab947b81dbd9d3e896be89e28c4a62cf720837 | |
| ToppCell | facs-Skin-nan-18m-Epithelial-Basal_IFE|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.98e-05 | 189 | 167 | 6 | 6c71e81373cb7822de23c193a6350b6df9f567bc | |
| ToppCell | 343B-Epithelial_cells-Epithelial-F_(Ciliated)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.98e-05 | 189 | 167 | 6 | ebc16b8eab84167d74446783d7e802acedc6b9c6 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.98e-05 | 189 | 167 | 6 | 164ea92ff6a1aa2ead1c9b8f64f99a9d65437232 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.98e-05 | 189 | 167 | 6 | 8ff3c3232eff9de4b5c9b22ecb82bc509d773f58 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.98e-05 | 189 | 167 | 6 | 975c0f079903ae36b0ffa54e86294d42ec7697de | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.98e-05 | 189 | 167 | 6 | a85099bd598a27ee64ee0664d051d89fa8d62fc9 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.21e-05 | 190 | 167 | 6 | f573fef3762a30c38cf8fa7f45df0ffbb49dc873 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-F_(Ciliated)|343B / Donor, Lineage, Cell class and subclass (all cells) | 8.21e-05 | 190 | 167 | 6 | 169e600e95878000acf5d11f813f9028c7249646 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-F_(Ciliated)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 8.21e-05 | 190 | 167 | 6 | 0cc36117c793d83cf4a1f66f47758a07d6712bd3 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.45e-05 | 191 | 167 | 6 | 51f5af610983aa73b9f4ece6f27d281ebff89a04 | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal-Deuterosomal_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.45e-05 | 191 | 167 | 6 | e8d56e9f43943e9cc4dce83f2c234f19c2dd487d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.45e-05 | 191 | 167 | 6 | 8fd6bdc9d2b1c8d364221d7bc68d03921b668ab5 | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.45e-05 | 191 | 167 | 6 | 52e8d7dfaf1ebb6df8bf3a1f4546af59faa67657 | |
| ToppCell | ASK428-Epithelial-Ciliated|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 8.45e-05 | 191 | 167 | 6 | 0c4b926a28bc94f3cf4d68a911c0a189f6ff505e | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.45e-05 | 191 | 167 | 6 | ece87127f85939e61b1048d968ed96f0e87c3a79 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.45e-05 | 191 | 167 | 6 | 478e8341ee03b05501e2233e02cef5f97492c95d | |
| ToppCell | (12)_SLC16A7+|World / shred by cell type by condition | 8.45e-05 | 191 | 167 | 6 | e427eeddd2e87c14376a37db0b43f120c90436bc | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.70e-05 | 192 | 167 | 6 | 0bb06738e1c3ec0c044a7ee61f6cf1d4781fb53c | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 8.70e-05 | 192 | 167 | 6 | be592e661367affced9ebe80849b466e6adb3a34 | |
| ToppCell | ASK428-Epithelial-Ciliated|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 8.70e-05 | 192 | 167 | 6 | 356ebddd03aec341b79890977edb8ff0804999a1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 5.25e-05 | 49 | 90 | 5 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Drug | AC1L1OBF | 4.71e-09 | 20 | 165 | 6 | CID000032736 | |
| Drug | NNAL | 1.03e-07 | 32 | 165 | 6 | CID000104856 | |
| Drug | R(-)-Denopamine | 1.25e-07 | 33 | 165 | 6 | CID000003818 | |
| Drug | C1 11-32 | 1.49e-07 | 18 | 165 | 5 | CID000443077 | |
| Drug | C11131 | 1.49e-07 | 18 | 165 | 5 | CID000443076 | |
| Drug | 3-[(3S,5R,10S,13R,14S,17R)-3-[(2S,4R,5R,6S)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one | 1.80e-07 | 35 | 165 | 6 | CID010436171 | |
| Drug | estriol-16-glucuronide | 3.48e-07 | 21 | 165 | 5 | CID000122281 | |
| Drug | testosterone glucuronide | 4.82e-07 | 41 | 165 | 6 | CID000108192 | |
| Drug | estradiol-3-glucuronide | 5.70e-07 | 23 | 165 | 5 | CID000066651 | |
| Drug | 4-nitrophenyl)imidazole | 8.44e-07 | 11 | 165 | 4 | CID000123155 | |
| Drug | aniline | 9.71e-07 | 142 | 165 | 9 | CID000006115 | |
| Drug | cotinine-N-glucuronide | 1.81e-06 | 13 | 165 | 4 | CID000000411 | |
| Drug | 7-hydroxycoumarin glucuronide | 1.94e-06 | 29 | 165 | 5 | CID000125641 | |
| Drug | AC1L9E0Q | 2.32e-06 | 30 | 165 | 5 | CID000443095 | |
| Drug | AC1Q6OQG | 3.79e-06 | 33 | 165 | 5 | CID000009686 | |
| Drug | BP-3,6-quinol | 3.79e-06 | 33 | 165 | 5 | CID000119292 | |
| Drug | 1'-hydroxyestragole | 4.52e-06 | 16 | 165 | 4 | CID000040003 | |
| Drug | p-nitroanisole | 4.83e-06 | 92 | 165 | 7 | CID000007485 | |
| Drug | AC1NOWCJ | 5.12e-06 | 35 | 165 | 5 | CID005120112 | |
| Drug | estrone-3-glucuronide | 5.12e-06 | 35 | 165 | 5 | CID000115255 | |
| Drug | 3-OHBaP | 6.39e-06 | 63 | 165 | 6 | CID000025890 | |
| Drug | IC261 | 6.41e-06 | 96 | 165 | 7 | CID000003674 | |
| Drug | l-borneol | 6.80e-06 | 37 | 165 | 5 | CID000010049 | |
| Drug | DB04103 | 6.87e-06 | 97 | 165 | 7 | CID004469987 | |
| Drug | harmol | 1.01e-05 | 40 | 165 | 5 | CID000068094 | |
| Drug | Isotretinoin [4759-48-2]; Up 200; 13.4uM; PC3; HT_HG-U133A | 1.20e-05 | 193 | 165 | 9 | 7315_UP | |
| Drug | Azaguanine-8 [134-58-7]; Down 200; 26.2uM; MCF7; HT_HG-U133A | 1.25e-05 | 194 | 165 | 9 | 1670_DN | |
| Drug | N-NK | 1.28e-05 | 148 | 165 | 8 | CID000047289 | |
| Drug | ranirestat | 1.28e-05 | 7 | 165 | 3 | ctd:C115070 | |
| Drug | Etilefrine hydrochloride [534-87-2]; Up 200; 18.4uM; MCF7; HT_HG-U133A | 1.36e-05 | 196 | 165 | 9 | 4415_UP | |
| Drug | androsterone glucuronide | 1.45e-05 | 43 | 165 | 5 | CID000114833 | |
| Drug | 7,8-benzoquinoline | 1.45e-05 | 43 | 165 | 5 | CID000009191 | |
| Drug | Nifurtimox [23256-30-6]; Down 200; 14uM; MCF7; HT_HG-U133A | 1.48e-05 | 198 | 165 | 9 | 7328_DN | |
| Drug | MS-222 | 1.63e-05 | 44 | 165 | 5 | CID000011400 | |
| Drug | 16-epiestriol | 2.05e-05 | 77 | 165 | 6 | CID000003269 | |
| Drug | lithocholic acid | 2.22e-05 | 116 | 165 | 7 | CID000009903 | |
| Drug | fibrates | 2.48e-05 | 118 | 165 | 7 | CID000002797 | |
| Drug | salicylamide | 2.50e-05 | 48 | 165 | 5 | CID000005147 | |
| Drug | AS-3201 | 2.52e-05 | 24 | 165 | 4 | CID000153948 | |
| Drug | AC1MRQNQ | 3.04e-05 | 9 | 165 | 3 | CID003522271 | |
| Drug | DHPASiU | 3.04e-05 | 9 | 165 | 3 | CID000197602 | |
| Drug | 3-iodophenol | 3.04e-05 | 9 | 165 | 3 | CID000012272 | |
| Drug | AC1L4J7U | 3.04e-05 | 9 | 165 | 3 | CID000186631 | |
| Drug | Chebi:32663 | 3.04e-05 | 9 | 165 | 3 | CID005460873 | |
| Drug | scopoletin | 3.06e-05 | 50 | 165 | 5 | CID005280460 | |
| Drug | AC1NQGK1 | 3.71e-05 | 52 | 165 | 5 | CID005195977 | |
| Drug | licochalcone A | 4.10e-05 | 27 | 165 | 4 | ctd:C070840 | |
| Drug | pentoxyresorufin | 4.11e-05 | 87 | 165 | 6 | CID000107683 | |
| Drug | afloqualone | 5.22e-05 | 2 | 165 | 2 | ctd:C033541 | |
| Drug | AHTN | 5.48e-05 | 29 | 165 | 4 | CID000089440 | |
| Drug | 7-hydroxy-4-trifluoromethylcoumarin | 5.48e-05 | 29 | 165 | 4 | CID005375667 | |
| Drug | trans-3'-hydroxycotinine | 5.48e-05 | 29 | 165 | 4 | CID000000414 | |
| Drug | 4-aminobiphenyl | 5.64e-05 | 92 | 165 | 6 | CID000007102 | |
| Drug | O-phospho-DL-threonine | 5.91e-05 | 11 | 165 | 3 | CID000001016 | |
| Drug | AC1O5XMV | 5.91e-05 | 11 | 165 | 3 | CID006442661 | |
| Drug | tolcapone | 6.29e-05 | 30 | 165 | 4 | CID004659569 | |
| Drug | dihydroartemisinin | 6.29e-05 | 30 | 165 | 4 | CID000107770 | |
| Drug | phenolphthalein | 6.32e-05 | 58 | 165 | 5 | CID000004764 | |
| Drug | Rolitetracycline [751-97-3]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 6.33e-05 | 185 | 165 | 8 | 3369_DN | |
| Drug | urochloralic acid | 6.87e-05 | 59 | 165 | 5 | CID003036914 | |
| Drug | 4-hydroxybiphenyl | 6.87e-05 | 59 | 165 | 5 | CID000007103 | |
| Drug | 4-hydroxyestrone | 6.87e-05 | 59 | 165 | 5 | CID000018418 | |
| Drug | acetaminophen glucuronide | 6.87e-05 | 59 | 165 | 5 | CID000083944 | |
| Drug | SN-38G | 6.87e-05 | 59 | 165 | 5 | CID000443154 | |
| Drug | Iohexol [66108-95-0]; Down 200; 4.8uM; HL60; HT_HG-U133A | 7.08e-05 | 188 | 165 | 8 | 2461_DN | |
| Drug | 4'-HPPH | 7.18e-05 | 31 | 165 | 4 | CID000017732 | |
| Drug | UDP-alpha-d-xylopyranose | 7.45e-05 | 60 | 165 | 5 | CID000001165 | |
| Drug | S)-cotinine | 7.58e-05 | 97 | 165 | 6 | CID000000408 | |
| Drug | N-OH-DABZ | 7.84e-05 | 12 | 165 | 3 | CID000051366 | |
| Drug | 1-O-beta-D-glucopyranosyl-D-mannitol | 7.84e-05 | 12 | 165 | 3 | CID000088735 | |
| Drug | 2,4,6-TCB | 7.84e-05 | 12 | 165 | 3 | CID000037247 | |
| Drug | nonanoyl-N-methylglucamide | 7.84e-05 | 12 | 165 | 3 | CID000160090 | |
| Drug | 7,7,7-triphenylheptanoic acid | 7.84e-05 | 12 | 165 | 3 | CID000276709 | |
| Drug | Guanfacine hydrochloride [29110-48-3]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 7.91e-05 | 191 | 165 | 8 | 2634_DN | |
| Drug | 1-naphthol | 8.03e-05 | 98 | 165 | 6 | CID000007005 | |
| Drug | Muracein C | 8.16e-05 | 32 | 165 | 4 | CID003086323 | |
| Drug | NSC625381 | 9.23e-05 | 145 | 165 | 7 | CID000002592 | |
| Drug | Edrophonium chloride [116-38-1]; Up 200; 19.8uM; PC3; HT_HG-U133A | 9.47e-05 | 196 | 165 | 8 | 6655_UP | |
| Drug | Lidocaone hydrochloride [73-78-9]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 9.81e-05 | 197 | 165 | 8 | 1499_DN | |
| Drug | Pilocarpine nitrate [148-72-1]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 9.81e-05 | 197 | 165 | 8 | 3300_DN | |
| Drug | ezetimibe | 1.01e-04 | 147 | 165 | 7 | CID000150311 | |
| Drug | tritanol | 1.01e-04 | 13 | 165 | 3 | CID000006457 | |
| Drug | 5-azido-UDP-glucuronic acid | 1.01e-04 | 13 | 165 | 3 | CID003081279 | |
| Drug | Laudanosine (R,S) [1699-51-0]; Up 200; 11.2uM; PC3; HT_HG-U133A | 1.02e-04 | 198 | 165 | 8 | 7270_UP | |
| Drug | estragole | 1.04e-04 | 34 | 165 | 4 | CID000008815 | |
| Drug | (-)-Adenosine 3',5'-cyclic monophosphate [60-92-4]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 1.05e-04 | 199 | 165 | 8 | 3531_DN | |
| Drug | Nystatine [1400-61-9]; Down 200; 4.4uM; MCF7; HT_HG-U133A | 1.09e-04 | 200 | 165 | 8 | 4807_DN | |
| Drug | propranolol glucuronide | 1.28e-04 | 14 | 165 | 3 | CID000119515 | |
| Drug | PCB-61 | 1.28e-04 | 14 | 165 | 3 | CID000036401 | |
| Drug | glucoraphanin | 1.31e-04 | 36 | 165 | 4 | CID000656556 | |
| Drug | trifluoperazine | UGT1A5 SPTBN2 CHRNB1 TBC1D9 UGT1A4 UGT1A3 SPTBN5 DNAAF10 UGT2B15 ATP2A1 | 1.32e-04 | 324 | 165 | 10 | CID000005566 |
| Drug | Meldola | 1.36e-04 | 68 | 165 | 5 | CID000081507 | |
| Drug | nitrosamine | 1.56e-04 | 70 | 165 | 5 | CID000037183 | |
| Drug | 2,2',3,5,5'-pentachlorobiphenyl | 1.60e-04 | 15 | 165 | 3 | CID000040469 | |
| Drug | afloqualone | 1.60e-04 | 15 | 165 | 3 | CID000002040 | |
| Drug | naphthyl sulphate | 1.60e-04 | 15 | 165 | 3 | CID000114775 | |
| Drug | coumarin-3-carboxylic acid | 1.60e-04 | 15 | 165 | 3 | CID000010752 | |
| Drug | sulforaphane nitrile | 1.60e-04 | 15 | 165 | 3 | CID000543743 | |
| Drug | acacetin | 1.62e-04 | 38 | 165 | 4 | CID005280442 | |
| Drug | AC1LCF1F | 1.77e-04 | 161 | 165 | 7 | CID000627275 | |
| Disease | nicotine dependence | 4.15e-06 | 78 | 159 | 6 | EFO_0003768 | |
| Disease | X-11793--oxidized bilirubin measurement | 8.43e-06 | 8 | 159 | 3 | EFO_0021260 | |
| Disease | Succinimide measurement | 8.43e-06 | 8 | 159 | 3 | EFO_0022118 | |
| Disease | X-11530 measurement | 8.43e-06 | 8 | 159 | 3 | EFO_0021249 | |
| Disease | sulfate of piperine metabolite C16H19NO3 (2) measurement | 8.43e-06 | 8 | 159 | 3 | EFO_0801034 | |
| Disease | cholelithiasis, bilirubin measurement | 8.43e-06 | 8 | 159 | 3 | EFO_0004570, EFO_0004799 | |
| Disease | X-11522 measurement | 8.43e-06 | 8 | 159 | 3 | EFO_0800696 | |
| Disease | X-10458 measurement | 8.43e-06 | 8 | 159 | 3 | EFO_0800692 | |
| Disease | X-24849 measurement | 8.43e-06 | 8 | 159 | 3 | EFO_0800909 | |
| Disease | membrane-associated progesterone receptor component 1 measurement | 8.43e-06 | 8 | 159 | 3 | EFO_0802740 | |
| Disease | X-16946 measurement | 8.43e-06 | 8 | 159 | 3 | EFO_0800766 | |
| Disease | X-11442 measurement | 1.26e-05 | 9 | 159 | 3 | EFO_0021236 | |
| Disease | X-11441 measurement | 1.26e-05 | 9 | 159 | 3 | EFO_0021235 | |
| Disease | circulating cell free DNA measurement | 1.26e-05 | 9 | 159 | 3 | EFO_0004739 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (3) measurement | 1.26e-05 | 9 | 159 | 3 | EFO_0801037 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (1) measurement | 1.26e-05 | 9 | 159 | 3 | EFO_0801036 | |
| Disease | X-11880 measurement | 1.26e-05 | 9 | 159 | 3 | EFO_0800698 | |
| Disease | protein-tyrosine kinase 6 measurement | 1.26e-05 | 9 | 159 | 3 | EFO_0020691 | |
| Disease | testis-specific chromodomain protein Y 1 measurement | 1.26e-05 | 9 | 159 | 3 | EFO_0802127 | |
| Disease | bilirubin measurement, response to xenobiotic stimulus | 1.26e-05 | 9 | 159 | 3 | EFO_0004570, GO_0009410 | |
| Disease | bilirubin measurement, response to tenofovir | 1.79e-05 | 10 | 159 | 3 | EFO_0004570, EFO_0009279 | |
| Disease | X-21448 measurement | 1.79e-05 | 10 | 159 | 3 | EFO_0800816 | |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | 1.79e-05 | 10 | 159 | 3 | EFO_0802185 | |
| Disease | X-23974 measurement | 1.79e-05 | 10 | 159 | 3 | EFO_0800867 | |
| Disease | plasma N-desmethylclozapine measurement | 2.45e-05 | 11 | 159 | 3 | EFO_0600039 | |
| Disease | histidine betaine (hercynine) measurement | 2.45e-05 | 11 | 159 | 3 | EFO_0800972 | |
| Disease | X-21796 measurement | 2.45e-05 | 11 | 159 | 3 | EFO_0800825 | |
| Disease | insomnia, bilirubin measurement | 2.45e-05 | 11 | 159 | 3 | EFO_0004570, EFO_0004698 | |
| Disease | aldosterone measurement | 2.45e-05 | 11 | 159 | 3 | EFO_0010219 | |
| Disease | X-15492 measurement | 2.89e-05 | 2 | 159 | 2 | EFO_0800752 | |
| Disease | bilirubin measurement | SOX5 UBR1 BANF2 UGT1A5 DDX42 BIRC6 UGT1A4 UGT1A3 UGT2B15 RORA DNAH11 | 2.99e-05 | 442 | 159 | 11 | EFO_0004570 |
| Disease | p-cresol glucuronide measurement | 3.26e-05 | 12 | 159 | 3 | EFO_0800079 | |
| Disease | biliverdin measurement | 3.26e-05 | 12 | 159 | 3 | EFO_0021033 | |
| Disease | Intellectual Disability | AKAP6 PIGB STT3B LINS1 SACS NFIA RORA TAF2 MED23 DYNC1H1 GOT2 | 3.31e-05 | 447 | 159 | 11 | C3714756 |
| Disease | retinol dehydrogenase 16 measurement | 4.22e-05 | 13 | 159 | 3 | EFO_0802007 | |
| Disease | heart disease (implicated_via_orthology) | 5.19e-05 | 38 | 159 | 4 | DOID:114 (implicated_via_orthology) | |
| Disease | testosterone measurement | SOX6 SOX5 UBR1 DLGAP1 KIF27 UGT1A5 AKR1D1 UNC13D BIRC6 CHRNB1 UGT1A4 SEMA3D NFIA AKR1B15 UGT2B15 UGT2B17 RORA MED23 ATP2A1 | 6.04e-05 | 1275 | 159 | 19 | EFO_0004908 |
| Disease | cholic acid glucuronide measurement | 8.63e-05 | 3 | 159 | 2 | EFO_0800574 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 9.88e-05 | 17 | 159 | 3 | EFO_0004611, EFO_0007800 | |
| Disease | angiopoietin-related protein 1 measurement | 1.18e-04 | 18 | 159 | 3 | EFO_0801382 | |
| Disease | etiocholanolone glucuronide measurement | 1.40e-04 | 19 | 159 | 3 | EFO_0800362 | |
| Disease | advanced sleep phase syndrome (is_implicated_in) | 1.72e-04 | 4 | 159 | 2 | DOID:0050628 (is_implicated_in) | |
| Disease | X-25937 measurement | 1.72e-04 | 4 | 159 | 2 | EFO_0800937 | |
| Disease | hereditary spastic paraplegia 12 (implicated_via_orthology) | 1.72e-04 | 4 | 159 | 2 | DOID:0110765 (implicated_via_orthology) | |
| Disease | X-17340 measurement | 1.72e-04 | 4 | 159 | 2 | EFO_0800773 | |
| Disease | tissue factor measurement | 1.90e-04 | 21 | 159 | 3 | EFO_0010623 | |
| Disease | urate measurement, spine bone mineral density | 2.75e-04 | 58 | 159 | 4 | EFO_0004531, EFO_0007701 | |
| Disease | DiGeorge syndrome (is_implicated_in) | 2.85e-04 | 5 | 159 | 2 | DOID:11198 (is_implicated_in) | |
| Disease | lung squamous cell carcinoma (is_implicated_in) | 2.86e-04 | 24 | 159 | 3 | DOID:3907 (is_implicated_in) | |
| Disease | gallstones | 3.04e-04 | 108 | 159 | 5 | EFO_0004210 | |
| Disease | Schizophrenia | SOX5 DLGAP1 ABCA1 SPTBN2 GRID1 SLC1A1 CHRNA5 ADCYAP1R1 UGT1A3 SEMA3D PDIK1L OXSR1 ATM CADPS2 | 3.18e-04 | 883 | 159 | 14 | C0036341 |
| Disease | Ischemic stroke | 3.92e-04 | 324 | 159 | 8 | HP_0002140 | |
| Disease | cotinine measurement, trans-3-hydroxycotinine measurement | 4.27e-04 | 6 | 159 | 2 | EFO_0007813, EFO_0010707 | |
| Disease | vitamin D measurement | 4.98e-04 | 336 | 159 | 8 | EFO_0004631 | |
| Disease | xanthurenate measurement | 5.06e-04 | 29 | 159 | 3 | EFO_0010551 | |
| Disease | response to dolutegravir | 5.60e-04 | 30 | 159 | 3 | EFO_0600017 | |
| Disease | HMG CoA reductase inhibitor use measurement | 5.79e-04 | 189 | 159 | 6 | EFO_0009932 | |
| Disease | X-24574 measurement | 5.95e-04 | 7 | 159 | 2 | EFO_0800897 | |
| Disease | androsterone sulfate measurement | 7.44e-04 | 33 | 159 | 3 | EFO_0021117 | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 7.74e-04 | 276 | 159 | 7 | EFO_0004612, EFO_0020943 | |
| Disease | deoxycholic acid glucuronide measurement | 7.91e-04 | 8 | 159 | 2 | EFO_0800575 | |
| Disease | serum N-desmethylclozapine measurement | 7.91e-04 | 8 | 159 | 2 | EFO_0600043 | |
| Disease | free androgen index | 9.97e-04 | 374 | 159 | 8 | EFO_0007005 | |
| Disease | neutral ceramidase measurement | 1.01e-03 | 9 | 159 | 2 | EFO_0008247 | |
| Disease | afamin measurement | 1.01e-03 | 9 | 159 | 2 | EFO_0008015 | |
| Disease | X-12844 measurement | 1.01e-03 | 9 | 159 | 2 | EFO_0021339 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 1.16e-03 | 145 | 159 | 5 | DOID:1289 (implicated_via_orthology) | |
| Disease | Myopia | 1.20e-03 | 385 | 159 | 8 | HP_0000545 | |
| Disease | 4-androsten-3alpha,17alpha-diol monosulfate (3) measurement | 1.26e-03 | 10 | 159 | 2 | EFO_0022090 | |
| Disease | Peripheral T-Cell Lymphoma | 1.26e-03 | 10 | 159 | 2 | C0079774 | |
| Disease | myelodysplastic syndrome | 1.26e-03 | 10 | 159 | 2 | EFO_0000198 | |
| Disease | Inherited neuropathies | 1.31e-03 | 40 | 159 | 3 | C0598589 | |
| Disease | periodontitis | 1.36e-03 | 223 | 159 | 6 | EFO_0000649 | |
| Disease | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement | 1.43e-03 | 307 | 159 | 7 | EFO_0004612, EFO_0020946 | |
| Disease | nevus count, cutaneous melanoma | 1.51e-03 | 91 | 159 | 4 | EFO_0000389, EFO_0004632 | |
| Disease | DNA repair protein RAD51 homolog 4 measurement | 1.54e-03 | 11 | 159 | 2 | EFO_0801531 | |
| Disease | pregnenetriol sulfate measurement | 1.54e-03 | 11 | 159 | 2 | EFO_0800586 | |
| Disease | free cholesterol measurement, high density lipoprotein cholesterol measurement | 1.66e-03 | 315 | 159 | 7 | EFO_0004612, EFO_0008591 | |
| Disease | lifestyle measurement | 1.78e-03 | 235 | 159 | 6 | EFO_0010724 | |
| Disease | uric acid measurement | SOX5 ABCA1 BANF2 RDH14 BIRC6 TFAP2B ADCYAP1R1 TBXT OXSR1 CACNA2D3 | 1.81e-03 | 610 | 159 | 10 | EFO_0004761 |
| Disease | 5alpha-androstan-3beta,17beta-diol monosulfate (2) measurement | 1.84e-03 | 12 | 159 | 2 | EFO_0800291 | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 2.10e-03 | 243 | 159 | 6 | EFO_0004612, EFO_0020944 | |
| Disease | X-11444 measurement | 2.16e-03 | 13 | 159 | 2 | EFO_0021237 | |
| Disease | DEAFNESS, AUTOSOMAL RECESSIVE (disorder) | 2.16e-03 | 13 | 159 | 2 | C1846647 | |
| Disease | pregnenetriol disulfate measurement | 2.16e-03 | 13 | 159 | 2 | EFO_0800587 | |
| Disease | androstenediol (3alpha, 17alpha) monosulfate (3) measurement | 2.16e-03 | 13 | 159 | 2 | EFO_0800293 | |
| Disease | X-19141 measurement | 2.16e-03 | 13 | 159 | 2 | EFO_0800799 | |
| Disease | phosphoglycerides measurement | 2.22e-03 | 48 | 159 | 3 | EFO_0022291 | |
| Disease | Seizures, Focal | 2.46e-03 | 104 | 159 | 4 | C0751495 | |
| Disease | membranous glomerulonephritis (biomarker_via_orthology) | 2.52e-03 | 14 | 159 | 2 | DOID:10976 (biomarker_via_orthology) | |
| Disease | Malformations of Cortical Development | 2.52e-03 | 14 | 159 | 2 | C1955869 | |
| Disease | Kartagener syndrome (implicated_via_orthology) | 2.52e-03 | 14 | 159 | 2 | DOID:0050144 (implicated_via_orthology) | |
| Disease | Cortical Dysplasia | 2.52e-03 | 14 | 159 | 2 | C0431380 | |
| Disease | 5alpha-androstan-3alpha,17alpha-diol monosulfate measurement | 2.52e-03 | 14 | 159 | 2 | EFO_0800283 | |
| Disease | free cholesterol to total lipids in small HDL percentage | 2.65e-03 | 51 | 159 | 3 | EFO_0022285 | |
| Disease | response to irinotecan | 2.89e-03 | 15 | 159 | 2 | EFO_0004829 | |
| Disease | interleukin 1 receptor antagonist measurement | 2.95e-03 | 53 | 159 | 3 | EFO_0004754 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 3.03e-03 | 447 | 159 | 8 | EFO_0000694, MONDO_0100096 | |
| Disease | prostate carcinoma | CCHCR1 SOX13 WTAP TBC1D9 TASOR2 DNASE2B DNAH12 ANLN ATM MAP3K21 FERMT2 DNAH11 | 3.32e-03 | 891 | 159 | 12 | EFO_0001663 |
| Disease | metabolite measurement | CLTCL1 UGT1A5 AKR1D1 CA10 UGT1A4 UGT1A3 UGT2B15 UGT2B17 GOT2 | 3.46e-03 | 560 | 159 | 9 | EFO_0004725 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| WLNEDIMLRTLKVTF | 166 | Q99952 | |
| KEIAIWAERIMFSDL | 241 | Q9BXT4 | |
| LDLAVFWVEFVMRHK | 456 | P35503 | |
| LVWFMARVIIDNKDG | 51 | Q8WW43 | |
| MDFILWPRNDIEKIV | 111 | Q9GZU0 | |
| KEGILDAIMVWFVLQ | 401 | Q6P2P2 | |
| IRQATVKWAMLEQIR | 4731 | Q9NR09 | |
| LKRVEIMAQCEEWIA | 4761 | Q9NR09 | |
| WEKLTFLIQGFREMI | 426 | Q8NEC5 | |
| EEEMLLWRRFLDNKV | 426 | Q96QU6 | |
| ALNKNVRFVELLMWR | 301 | P51857 | |
| IFRMLVLRVAAEDVW | 31 | Q969M2 | |
| EVWLINKSMELLDER | 516 | O95477 | |
| MDVELRRFAKEIWSL | 1356 | Q96DT5 | |
| LKEDWQFVAMVVDRL | 456 | P11230 | |
| FLKLLQAERDRMEGW | 796 | O14490 | |
| WEMLKFEVALRLETL | 536 | Q3MIX3 | |
| AAAWEKMEARLERVL | 531 | Q8N283 | |
| AMWQLALALIFKIVV | 441 | P51793 | |
| FWINKVNLKMREITE | 191 | Q5T5Y3 | |
| QRKWDELAVQEKMFR | 56 | Q5JU67 | |
| RLFMILWLKGVVFNV | 196 | Q9NZA1 | |
| IFKLRALDLTQWLMV | 956 | O14983 | |
| RDQAAIMLWKLVENV | 6 | Q92481 | |
| ESMLVEWEQVKQRIL | 131 | Q8N1F7 | |
| RQADKVWRLDLVMVI | 121 | Q12857 | |
| KQLDLAALIVYWEME | 46 | Q9NZQ7 | |
| DVKECLWFVLEILMA | 1016 | Q9NTI5 | |
| KRQVMFLAILLLLWE | 11 | Q9Y5E4 | |
| VDQLRDIKECLWFML | 1021 | Q29RF7 | |
| EKSFLNIREWVDMIE | 626 | Q8IZ41 | |
| WLRVDALVAIFMVLA | 156 | A8MUP6 | |
| SFVVKDELWLVMKLL | 81 | O95747 | |
| LVDLKWRFNLLVFTM | 81 | P48544 | |
| RQADKVWRLDLVMVI | 121 | Q14938 | |
| KWLSRVFIEQDDDML | 436 | Q8NG48 | |
| NSVLAERLEKWLQLM | 266 | O14920 | |
| SVQRLLWEVEEMLFE | 281 | A5PLN7 | |
| RNLLDSMVLITDKFW | 291 | P35052 | |
| LARNLKRVAEVWMDE | 386 | Q86SR1 | |
| DLWMQKLNQVLVDIR | 1096 | Q9NQW6 | |
| MQFVLSWVFLVAILK | 1 | P0DTE1 | |
| DIKLFDLRNMALRWE | 191 | Q96MX6 | |
| KELLDLAMQNAWFRK | 626 | Q86XP3 | |
| LVLAQRWMERLKTVA | 76 | P49771 | |
| EWFNMIQEVRKAVLT | 441 | Q86VH2 | |
| RDEWIFADMELLRKV | 1836 | Q96RV3 | |
| VMLNLTERHIKIWFQ | 181 | P52945 | |
| ALQEEQARLKMRLWD | 11 | P80217 | |
| IKGRDHLMWVLLQFI | 366 | Q9ULK4 | |
| EKWLIQVEDLMLRSV | 1066 | Q6ZR08 | |
| EQAELRRWEHLIFMK | 821 | Q86UK5 | |
| KERWLVAGLSMQIFA | 91 | Q6W3E5 | |
| TIILWAMKFRLEKEN | 221 | A6NDL7 | |
| EELWPVVAFLKNDMI | 91 | Q9H0R1 | |
| MEIDNQTWVREFILL | 1 | O95006 | |
| AKILSVVIWAFMFLL | 141 | Q9H244 | |
| IWLMNEEEAKDLIAR | 401 | Q96MC2 | |
| IMNWERITDRLKTAF | 1031 | Q86Y13 | |
| IELADAFEQMWQKRR | 181 | Q92643 | |
| FMLRAISVFIKDWIL | 196 | P41586 | |
| KLMEDVQIDWTIRDL | 2166 | Q9UMZ3 | |
| WVLINLALLMKEAEL | 201 | O76062 | |
| VVEDWKFIAQVLDRM | 416 | P30532 | |
| KLFEDKELQWTFIML | 1701 | Q13315 | |
| IDWLVQVQMKFRLLQ | 206 | P14635 | |
| NIMEKLFLWSLRREF | 96 | Q05DH4 | |
| DEMTRIIWQFIKEKL | 56 | P48735 | |
| FLDDIFAAWMAQRLK | 246 | Q8WZ79 | |
| LLMHKNEAEFQRWLI | 51 | Q9H503 | |
| VRLLKELWDMVVVVN | 1276 | Q9UFH2 | |
| LIGREAAFADNLKWM | 396 | Q8IZS8 | |
| VKWIMTELVLFLVEF | 931 | Q8IZS8 | |
| ELLTEKEVAMIFVNW | 1271 | Q15811 | |
| IFRAWFNMVREVKID | 841 | Q8NCU4 | |
| EKWLVELERVMINSI | 1141 | Q8WXX0 | |
| EWEDKANEFQRMLII | 3371 | Q8WXX0 | |
| MKVICVWLTDRLDLQ | 1211 | Q86UW7 | |
| QSLLNRWREKVFALM | 331 | Q8TD31 | |
| RWREKVFALMVQLKA | 336 | Q8TD31 | |
| LAMKINLTEARVQVW | 66 | A6NNA5 | |
| EMALEEFLKQIREVW | 1456 | Q14204 | |
| LSWEDKLNRIMALFD | 1521 | Q14204 | |
| KLNRIMALFDVWIDV | 1526 | Q14204 | |
| DVMLRLVTELRWQKF | 151 | Q9ULK0 | |
| AVRRLIWEKNLKFVM | 46 | P25774 | |
| IRDRMWLKITIANAV | 431 | O14640 | |
| LFVKELFWMLHLQKE | 106 | Q8IYV9 | |
| TDFKVMARDELILRW | 16 | Q15007 | |
| RWLVAMFDFIDRKEQ | 166 | Q92674 | |
| LIEAKMRFIQAWQSL | 551 | Q96AC1 | |
| IRDRMWLKITIANAV | 406 | P54792 | |
| ELAKQLWMVLQRSLV | 186 | O60645 | |
| MEIVWEVLFLLQANF | 1 | Q9NS85 | |
| ERFARLIKEVMNTFW | 741 | Q9NZJ4 | |
| MVRWKLQVLDLQDVC | 1 | H0Y7S4 | |
| IIAVDWLLDRFRTMV | 436 | P43005 | |
| MKWVESIFLIFLLNF | 1 | P02771 | |
| MEWENQTILVEFFLK | 1 | Q8NGT0 | |
| WMFALDSIIRKAVQT | 1151 | Q99683 | |
| VLFWGVREMKKVQLL | 996 | Q2WGJ9 | |
| LMKQLENQEVARWVF | 161 | Q92521 | |
| VEDLVDSLKLAVFMW | 951 | O95197 | |
| VQDLVDSLKFAVLMW | 696 | Q16799 | |
| MDEVFDLKERNQWLR | 791 | Q9Y5W8 | |
| GRLIIRAEELAQMWK | 81 | Q9BZX4 | |
| TWEFLRLILDLSMKV | 291 | P52788 | |
| QRMKIDREFALWLKD | 551 | A6NHR9 | |
| VAFIIGSLWDKERLM | 91 | Q16613 | |
| LIERLEQAWMNEKFA | 26 | Q9BRT9 | |
| WLQVENSKLVRIIAM | 816 | Q6ZMZ3 | |
| MLRKLTIEQINDWFT | 1 | Q8NDG6 | |
| WKLEIQQMFDELRTK | 421 | Q5TCX8 | |
| VLRKVEFEQADFMWQ | 636 | Q6P1X5 | |
| VFARVMIFLDWIQSK | 796 | Q7RTY7 | |
| AKADIFALGIIIWAM | 236 | Q8N165 | |
| KVNWFKNRDEMLVVL | 2471 | Q96Q15 | |
| RWVQETKLLAQARVM | 1181 | P58107 | |
| GQEKILLWLLQFMQE | 431 | Q9Y6H5 | |
| RAQFLITFKTMEEIW | 106 | Q8TF17 | |
| DMELVQVFLWLAQVL | 916 | Q8TF17 | |
| FSEVNGDRLIWLVKM | 386 | P49221 | |
| ARKLWDISEVMVGLL | 321 | Q9HBH5 | |
| ELMKVLIDWINDVLV | 96 | Q9NVD7 | |
| WKFQRTRVLMDIVAN | 116 | Q96J65 | |
| ADLLRWIAEKQMQLE | 316 | Q9NRC6 | |
| KWNMEEVVLEELQIF | 486 | O95025 | |
| SNRWLMVKIFLILIV | 331 | Q13190 | |
| MEQAIRAELWKVLDV | 271 | Q8TE77 | |
| NAFMVWAKDERRKIL | 626 | P35712 | |
| KAVMREDLFIVSKVW | 66 | C9JRZ8 | |
| LRKQWLQEVKVMADR | 336 | P00505 | |
| IIVNLERRWEAIVMQ | 1166 | Q13023 | |
| KMLEHLELFWSRVNI | 1331 | P53675 | |
| KLWQLVAMAKIERFS | 251 | Q96M20 | |
| LLFWKNTAVVREMTE | 791 | Q9UNS1 | |
| EVLTFKEINWQMIRI | 176 | A0JNW5 | |
| VVLFAWMQFLKEETL | 121 | Q9UBS8 | |
| ASFEIDKRRIELNMW | 46 | P52198 | |
| FMVWAKDERRKILQA | 431 | Q9UN79 | |
| ATAIMEAVVREWILL | 71 | Q9C0E2 | |
| QKSLWIQLLEEMFLG | 2161 | Q8N2C7 | |
| INVSLMWLSFRKVQE | 141 | Q9BQB6 | |
| MDWLQLVLEVLVFGR | 2006 | O15020 | |
| LREWEAQDMRVTLFK | 26 | P57738 | |
| AQDMRVTLFKLLLLW | 31 | P57738 | |
| REVMWQLCAIKITEA | 316 | P35398 | |
| DINKFLWMVRIAEGE | 671 | Q8TCJ2 | |
| GRLIIRAEELAQMWK | 81 | Q9HAT0 | |
| QAEMEEWVKFLRRVA | 136 | P42331 | |
| FLMGREAKLVIRWVD | 191 | Q6ZT07 | |
| LDLAVFWVEFVMRHK | 456 | P35504 | |
| TWILQMFDTVKRLRE | 976 | Q8IWV7 | |
| WESKAQVLFFLVIMV | 281 | P55017 | |
| QLTRKEWIQFMVEAE | 331 | Q8IYM2 | |
| DWEAQLRRIMKLIAG | 251 | Q86VZ5 | |
| LWLRFKELTNEMIVT | 51 | O15178 | |
| TAWKRALRIFIMFDV | 276 | A6NFE2 | |
| IEILWSQFLKFKEME | 451 | Q15149 | |
| ALVLKMQLFLARQDW | 216 | Q8NDW8 | |
| ILALQKWIIDLAMNL | 106 | Q8N755 | |
| WVLTVLSLKFVFEML | 86 | Q969S6 | |
| DQRLKFWDMAQLRAV | 316 | Q9H6Y2 | |
| NAFMVWAKDERRKIL | 561 | P35711 | |
| SKNIMLIDVREIWEI | 41 | H0UI37 | |
| VEEVKLLLHMWVALF | 786 | Q5VWN6 | |
| ILVFDLLIVMQDWEF | 246 | Q9H0C3 | |
| IRKTLRLWMDDVNEQ | 466 | Q96AX1 | |
| KPLDRAVFWIEFVMR | 456 | P54855 | |
| VASLADDKMVRFWRI | 326 | Q9Y6I7 | |
| FQMTILRDLEKLAGW | 676 | Q6PJF5 | |
| LFSMAFRELQWLVAK | 521 | Q70J99 | |
| KPLDRAVFWIEFVMR | 456 | O75795 | |
| VVSLEWLRMFDQQEI | 946 | Q15386 | |
| LDLAVFWVEFVMRHK | 456 | P22310 | |
| MAVRQWVIALALAAL | 1 | O60575 | |
| AVEILEKGQVRFWMQ | 1251 | P52179 |